Johnson & Johnson (JNJ) is a dividend growth stalwart, having delivered a growing dividend for over 50 years. Recently it has been quite over-valued, even though its dependable dividend does merit a premium. Over the last 3 months or so it has been moving down, and is now around $10 below its most recent high.
About 10 days ago, JNJ released its latest earnings report, and despite what looked like good numbers, it dropped even more. It has now recovered from that drop, but has the price now dropped enough to make this a good point to add more JNJ to your DG portfolio?
